• Antonio Fiore, Mariantonietta Piscitelli, Didier K Adodo, Charrier Thomas, DessapArmand MekontsoAMMedical Intensive Care Unit, DHU A-TVB, Henri-Mondor University Hospital, Assistance Publique -Hôpitaux de Paris (AP-HP), Créteil, France., François Bagate, and Thierry Folliguet.
• Department of Cardiac Surgery, DMU CARE, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, Créteil, France. Electronic address: antonio.fiore@aphp.fr.
• J. Cardiothorac. Vasc. Anesth. 2021 Jul 1; 35 (7): 214021432140-2143.

AbstractClinical manifestations of coronavirus disease 2019 in pregnant women, in contrast to previous outbreaks, seem to be similar to those of nonpregnant women. During severe acute respiratory syndrome (SARS), SARS influenza A, and Middle East respiratory syndrome outbreaks, an increased severity of disease among pregnant women was observed. In some pregnant women, respiratory failure can occur and progress quickly to acute respiratory distress syndrome requiring extracorporeal membrane oxygenation (ECMO) as a rescue therapy. Despite a lack of current guidelines on the use of ECMO in pregnant or postpartum women, this support therapy is an effective salvage therapy for patients with cardiac and/or respiratory failure, and is associated with favorable maternal and fetal outcomes. Herein, the authors report a case of severe COVID-19 disease in a pregnant patient after urgent cesarean delivery, who was treated successfully with ECMO during the postpartum. Extracorporeal membrane oxygenation should be considered early when conventional therapy is ineffective, and it is essential to refer to ECMO expert centers.Copyright © 2020 Elsevier Inc. All rights reserved.

14 keywords...

hide…